Literature DB >> 7924289

Topical provocation of fixed drug eruption. A study of 30 patients.

K Alanko1.   

Abstract

Topical provocation with the causative agent was performed in 30 patients with fixed drug eruption (FDE). The epicutaneous open test method was used on inactive sites of old FDE lesions. Drugs at 10% in the vehicles petrolatum, alcohol and dimethylsulfoxide (DMSO) were used as test preparations. Positive reactions were always seen with phenazone salicylate (16 patients) and carbamazepine patients (3 patients), and in an individual case from chlormezanone. Both positive and negative reactions were seen with trimethoprim (3 and 2, respectively), doxycycline (2 and 1) and sulfadiazine (1 and 1). Control tests on unaffected skin with drug preparations and pure vehicles remained negative. The present results confirm our previous observation that topical provocation is a reliable test method in FDE caused by phenazone salicylate. The present study also shows that topical provocation may be useful in FDE caused by carbamazepine. In FDE caused by trimethoprim, doxycycline and sulfonamides, a positive, but not a negative, skin reaction is informative.

Entities:  

Mesh:

Year:  1994        PMID: 7924289     DOI: 10.1111/j.1600-0536.1994.tb01900.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  7 in total

Review 1.  Recognising antibacterial hypersensitivity in children.

Authors:  A Romano
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence.

Authors:  Ingrid Böhm; Jesus Medina; Pilar Prieto; Wolfgang Block; Hans H Schild
Journal:  Eur Radiol       Date:  2006-08-26       Impact factor: 5.315

3.  Fixed drug eruption resulting from fluconazole use: a case report.

Authors:  Mahkam Tavallaee; Mahnaz Mahmoudi Rad
Journal:  J Med Case Rep       Date:  2009-07-06

4.  Patch testing in non-immediate drug eruptions.

Authors:  Antonino Romano; Marinella Viola; Francesco Gaeta; Gabriele Rumi; Michela Maggioletti
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

Review 5.  Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Fixed drug eruption induced by atenolol.

Authors:  H Belhadjali; O Trimech; M Youssef; I Elhani; J Zili
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-24

Review 7.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.